Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein

Circulation

Volumn 100, Issue 9, 1999, Pages 899-902

  Morawietz, Henning ^a   Rueckschloss, Uwe ^a   Niemann, Bernd ^a   Duerrschmidt, Nicole ^a   Galle, Jan ^c   Hakim, Kavous ^a   Zerkowski, Hans Reinhard ^a   Sawamura, Tatsuya ^b   Holtz, Juergen ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b KYOTO UNIVERSITY   (Japan)

^c NONE

Author keywords

Angiotensin; Atherosclerosis; Coronary disease; Endothelium; Lipoproteins

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; ATHEROGENESIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; FOAM CELL; HUMAN; HUMAN CELL; LIPID OXIDATION; PRIORITY JOURNAL;

EID: 0033621112     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.9.899     Document Type: Article

References (13)

1. Ross R. The pathogenesis of atherosclerosis: perspective for the 1990s. Nature. 1993;362:801-809.
2. Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation. 1997;94:1062-1071.
3. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344:160-162.
4. Khan BV, Parthasarathy SS, Alexander RW, Medford RM. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest. 1995;95:1262-1270.
5. Chai YC, Howe PH, DiCorleto PE, Chisolm GM. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells: evidence for release of fibroblast growth factor-2. J Biol Chem. 1996;271:17791-17797.
6. Galle J, Bengen J, Schollmeyer P, Wanner C. Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a): role of oxygen-derived radicals. Circulation. 1995;92:1582-1589.
7. Dimmeler S, Haendeler J, Galle J, Zeiher AM. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: a mechanistic clue to the "response to injury" hypothesis. Circulation. 1997;95:1760-1763.
8. Sawamura T, Kume N, Aoyama T, Moriwaki H, Hoshikawa H, Aiba Y, Tanaka T, Miwa S, Katsura Y, Kita T, Masaki T. An endothelial receptor for oxidized low-density lipoprotein. Nature. 1997;386:73-77.
9. Kume N, Murase T, Moriwaki H, Aoyama T, Sawamura T, Masaki T, Kita T. Inducible expression of lectin-like oxidized LDL receptor-1 in vascular endothelial cells. Circ Res. 1998;83:322-327.
10. Oka K, Sawamura T, Kikuta K, Itokawa S, Kume N, Kita T, Masaki T. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci U S A. 1998;95:9535-9540.
11. Galle J, Wanner C. Oxidized LDL and Lp(a): preparation, modification, and analysis. In: Armstrong D, ed. Free Radical and Antioxidant Protocols. Totowa, NJ: Humana Press; 1998:119-130.
12. Stephan ZF, Yirachek EC. Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL. J Lipid Res. 1993;34:325-330.
13. Yoshida H, Kondratenko N, Green S, Steinberg D, Quehenberger O. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem J. 1998;334:9-13.